RAPT Therapeutics, Inc. (RAPT)
NASDAQ: RAPT · Real-Time Price · USD
35.84
+0.44 (1.24%)
Dec 24, 2025, 1:00 PM EST - Market closed
RAPT Therapeutics Market Cap
RAPT Therapeutics has a market cap or net worth of $993.16 million as of December 24, 2025. Its market cap has increased by 2,328.19% in one year.
Market Cap
993.16M
Enterprise Value
838.41M
1-Year Change
2,328.19%
Ranking
Category
Stock Price
$35.84
Market Cap Chart
Since October 31, 2019, RAPT Therapeutics's market cap has increased from $276.64M to $993.16M, an increase of 259.01%. That is a compound annual growth rate of 23.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 24, 2025 | 993.16M | 365.76% |
| Dec 31, 2024 | 213.23M | -75.05% |
| Dec 29, 2023 | 854.75M | 27.19% |
| Dec 30, 2022 | 672.02M | -38.08% |
| Dec 31, 2021 | 1.09B | 123.77% |
| Dec 31, 2020 | 484.97M | -19.54% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 31, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 959.53B |
| Johnson & Johnson | 495.78B |
| AbbVie | 404.36B |
| UnitedHealth Group | 294.22B |
| AstraZeneca | 287.19B |
| Novartis AG | 267.64B |
| Merck & Co. | 260.71B |
| Novo Nordisk | 232.28B |